GUT CHECK: IS THE MICROBIOME THE KEY TO YOUR HEALTH?
Thursday, June 10, 2021
12:00 PM - 1:00 PM (ET)
Our microbiome - the trillions of microorganisms including bacteria, viruses, and fungi that live within us - is essential to our health. But disruptions of the microbial ecosystem are linked with human diseases including autoimmune diseases, inflammatory disorders, and obesity.
Join JAX for a discussion on this biodiverse ecosystem and how we can utilize it to improve our health.
For questions, contact Advancement Events at firstname.lastname@example.org.
Mark Adams, Ph.D., Deputy Director, JAX Genomic Medicine, Professor & Director, Clinical Diagnostic Research
Dr. Mark Adams is Deputy Director and Professor at The Jackson Laboratory for Genomic Medicine in Farmington, CT. He is an expert in genome-based analysis of antibiotic resistance in bacterial pathogens and he leads the clinical diagnostic research programs in the JAX-GM CLIA Laboratory.
Dr. Adams was a co-founder of The Institute for Genomic Research and Celera Genomics, where he led the DNA sequencing and genome annotation groups. From 2003-2011, Dr. Adams was Associate Professor of Genetics at Case Western Reserve University. From 2011-2016, he was the Scientific Director and Professor at the J. Craig Venter Institute.
Dr. Adams has a BA in Chemistry from Warren Wilson College and a Ph.D. in Biological Chemistry from the University of Michigan.
George Weinstock, Ph.D., Professor, Evnin Family Chair and Director of Microbial Genomics
Dr. George Weinstock is the Evnin Family Chair, Professor, and Director of Microbial Genomics at the Jackson Laboratory for Genomic Medicine where he established a group devoted to genomic studies of infectious diseases and the human microbiome. The group collaborates extensively with clinicians to apply genomic analyses to a wide range of medical problems. The goal of the metagenomics projects is to determine the role of the microbiome in health and disease with the aim of providing new diagnostic and therapeutic approaches. His group played a leading role in the NIH Human Microbiome Project including both basic science and clinical studies and his current research follows on those projects. Dr. Weinstock was previously the co-director of the Human Genome Sequencing Center at Baylor College of Medicine in Houston, Texas where he was one of the leaders of the Human Genome Project. He also directed a number of human and mammalian genetics projects aimed at determining genetic causes of conditions such as Retinitis Pigmentosa, Cleft Lip, susceptibility to infection, and the role of host genetics in control of the microbiome. He has also been an innovator in methods for microbial genetics, application of DNA sequencing in genomics, and software for genome analysis, as well as medical and agricultural applications of genomics. His research continues evolving with new issues in DNA sequencing technology.
The microbes are tiny, the promise is huge.
We depend on a vast army of microbes to stay alive: a microbiome that protects us against germs, breaks down food to release energy, and produces vitamins. But disruptions of this incredible ecosystem are linked with autoimmune diseases, inflammatory disorders, and obesity. JAX scientist George Weinstock, Ph.D., Director of Microbial Genomics and Evnin Family Chair, leads an interactive discussion on how a microbiome-based approach to living well can help us treat disease and enhance our health.